CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $35,678,234 | +58.5% | 928,637 | -4.5% | 2.44% | +42.6% |
| Q1 2023 | $22,506,222 | +33.7% | 972,191 | +51.3% | 1.71% | +16.0% |
| Q4 2022 | $16,839,264 | +51.0% | 642,720 | +13.3% | 1.48% | +42.6% |
| Q3 2022 | $11,155,000 | +16.0% | 567,415 | +3.2% | 1.03% | +13.8% |
| Q2 2022 | $9,617,000 | +320.5% | 549,854 | +293.3% | 0.91% | +457.7% |
| Q1 2022 | $2,287,000 | – | 139,818 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |